Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Oracle's earnings call highlights significant growth in cloud revenue, strong partnerships, and aggressive AI expansion plans. Year-over-year increases in key financial metrics, such as total revenue and EPS, coupled with strategic partnerships with Meta and NVIDIA, indicate strong market positioning. Despite unclear timelines for AI margin improvements, the optimistic guidance and robust financial performance suggest a positive stock price reaction.
Remaining Performance Obligations (RPO) $523.3 billion, up 433% year-over-year, driven by contracts signed with Meta, NVIDIA, and others, diversifying the customer backlog.
Total Cloud Revenue $8 billion, up 33% year-over-year, representing a significant acceleration from the 24% growth rate reported last year. Cloud revenue now accounts for half of Oracle's overall revenue.
Cloud Infrastructure Revenue $4.1 billion, up 66% year-over-year, with GPU-related revenue growing 177%. Growth attributed to faster expansion compared to competitors.
Cloud Database Services Revenue Up 30% year-over-year, with Autonomous Database revenue up 43% and Multicloud consumption up 817%.
Cloud Applications Revenue $3.9 billion, up 11% year-over-year. Strategic back-office applications revenue was $2.4 billion, up 16%.
Total Revenue $16.1 billion, up 13% year-over-year, higher than the 9% growth reported in Q2 last year, continuing the trend of accelerating total revenue growth.
Operating Income $6.7 billion, up 8% year-over-year.
Non-GAAP EPS $2.26, up 51% year-over-year.
GAAP EPS $2.10, up 86% year-over-year, including a pretax gain of $2.7 billion from the sale of interest in Ampere.
Operating Cash Flow $2.1 billion in Q2.
Free Cash Flow Negative $10 billion, with CapEx at $12 billion, reflecting investments in revenue-generating equipment for data centers.
Oracle AI database and AI data platform: Oracle introduced a new AI database and AI data platform that integrates AI models with private enterprise data, ensuring data privacy and security. This platform allows AI models to reason across all data sources, including Oracle and non-Oracle databases, enabling a unified view of business operations.
AI-based ambulatory EHR: Oracle launched a new AI-based ambulatory electronic health record (EHR) system, which has received U.S. regulatory approval and is now generally available.
Cloud infrastructure expansion: Oracle's OCI now operates 147 live customer-facing regions with 64 more planned. The company delivered 50% more GPU capacity this quarter compared to Q1 and launched 11 Multicloud regions, bringing the total to 45 live regions across AWS, Azure, and GCP.
AI partnerships and marketplace growth: Oracle added new AI models from Google, OpenAI, and xAI to its platform. Marketplace consumption grew 89% year-over-year, driven by partnerships with companies like Broadcom and Palo Alto.
Cloud revenue growth: Total cloud revenue grew 33% year-over-year to $8 billion, with cloud infrastructure revenue up 66% and cloud database services revenue up 30%. Multicloud consumption increased by 817%.
Sales reorganization: Oracle combined its industry-based cloud apps and Fusion cloud apps sales teams into a single organization, leading to increased cross-selling synergies and larger deal sizes.
AI-driven enterprise transformation: Oracle is positioning itself as a leader in AI-driven enterprise solutions by integrating AI capabilities across its database, applications, and cloud infrastructure. This strategy aims to enhance customer value and drive growth in AI-related services.
Focus on profitability and strategic investments: Oracle emphasized a rigorous evaluation process for infrastructure investments, ensuring alignment across components to deliver profitable and high-quality services.
Free Cash Flow: The company reported a negative free cash flow of $10 billion in Q2, primarily due to significant capital expenditures of $12 billion. This reflects the heavy investments being made to support growth, which could strain financial flexibility if not managed effectively.
Capital Expenditures: Oracle's capital expenditures are expected to increase by $15 billion in FY '26 compared to earlier forecasts. This significant rise in CapEx could impact profitability and cash flow if revenue growth does not materialize as expected.
Debt and Financing: The company relies on various debt structures and financing options, including public bonds, bank loans, and private debt markets. While Oracle aims to maintain its investment-grade debt rating, increased borrowing could pose financial risks if market conditions change.
Cloud Infrastructure Expansion: The rapid expansion of Oracle's cloud infrastructure, including 64 planned new regions, requires substantial investment and operational execution. Any delays or inefficiencies in this expansion could impact customer satisfaction and revenue growth.
AI Infrastructure Demand: While demand for AI infrastructure is strong, Oracle's ability to meet this demand depends on securing necessary components like GPUs and managing costs effectively. Supply chain disruptions or cost overruns could hinder growth.
Sales Force Reorganization: The ongoing reorganization of Oracle's sales force to unify selling across applications and industry solutions could temporarily disrupt sales operations and impact short-term revenue growth.
Regulatory Approvals in Healthcare: Oracle's new AI-based ambulatory EHR has received U.S. regulatory approval, but any future regulatory hurdles could delay product rollouts and revenue realization in the healthcare sector.
Customer Contract Execution: Oracle's rigorous process for accepting customer contracts ensures profitability but could limit growth opportunities if the company is unable to align all necessary components for execution.
Revenue Expectations: Oracle expects $4 billion of additional revenue in FY '27 due to added RPO in Q2. The full-year FY '26 revenue expectation remains at $67 billion.
Capital Expenditures: Fiscal 2026 CapEx is projected to be about $15 billion higher than previously forecasted after Q1, driven by investments to support growth.
Cloud Revenue Growth: For Q3, total cloud revenue is expected to grow 37%-41% in constant currency and 40%-44% in USD. Total revenues are expected to grow 16%-18% in constant currency and 19%-21% in USD.
Non-GAAP EPS: Non-GAAP EPS for Q3 is expected to grow 12%-14% in constant currency ($1.64-$1.68) and 16%-18% in USD ($1.70-$1.74).
Cloud Infrastructure Expansion: Oracle plans to expand its OCI regions from 147 to 211, with 64 new regions planned. The company is also increasing GPU capacity and delivering new AI infrastructure capabilities.
AI and Multicloud Growth: Oracle is seeing strong demand for AI infrastructure and Multicloud services, with Multicloud database consumption up 817% year-over-year. The company plans to launch 27 more Multicloud regions in the coming months.
AI Data Platform: Oracle is integrating AI models with its database and application platforms to enable multistep reasoning on private enterprise data, aiming to unlock significant value for customers.
Cloud Applications Growth: Cloud applications revenue is expected to accelerate, driven by synergies between back-office and industry applications, as well as the adoption of AI-driven solutions.
The selected topic was not discussed during the call.
Oracle's earnings call highlights significant growth in cloud revenue, strong partnerships, and aggressive AI expansion plans. Year-over-year increases in key financial metrics, such as total revenue and EPS, coupled with strategic partnerships with Meta and NVIDIA, indicate strong market positioning. Despite unclear timelines for AI margin improvements, the optimistic guidance and robust financial performance suggest a positive stock price reaction.
The earnings call indicates strong growth in cloud applications and infrastructure, with significant revenue increases in key areas like autonomous databases and multi-cloud solutions. Despite a slight dip in total software revenue and negative free cash flow due to high CapEx, the optimistic revenue and EPS guidance, coupled with strategic AI advancements, suggest positive stock movement. The Q&A highlights unique advantages in AI and enterprise applications, reinforcing a positive outlook. However, lack of specific ROI details on CapEx and some unclear management responses prevent a stronger positive rating.
The earnings call reveals strong financial performance, particularly in cloud revenue growth and optimistic future guidance, which are positive indicators for stock price. However, concerns about supply chain, economic factors, and CapEx risks temper the outlook. The shareholder return plan, with stable dividends and share repurchases, supports a positive sentiment. The Q&A section highlights strong demand and strategic positioning in AI and cloud, bolstering confidence despite some management vagueness. Overall, the positive factors outweigh the negatives, suggesting a likely stock price increase in the 2% to 8% range.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.